文献速递前列腺癌

整合家族史、多基因风险评分、DNA修复基因罕见变异与生活方式识别早期致死性前列腺癌风险患者

Identifying Patients at Risk of Early Lethal Prostate Cancer by Integrating Family History, Polygenic Risk Score, Rare Variants in DNA Repair Genes, and Lifestyle Factors.
PubMed 文献 · Eur Urol Oncol · 2025-04-04

研究纳入两个前瞻性队列中966例前列腺癌患者(富集高危局限期且有胚系遗传数据),评估家族史、PRS前20%、DNA修复基因罕见变异及生活方式评分与75岁前转移或前列腺癌死亡(早期致死)的关联。289例致死(含77例早期致死),≥2个遗传因素与早期致死风险升高相关(OR 3.5,95%CI 1.8-7.0),无遗传因素且健康者风险最低(OR 0.3,95%CI 0.1-0.7)。

要点

  • ≥2个遗传因素与早期致死风险升高相关(OR 3.5,95%CI 1.8-7.0)
  • 无遗传因素且生活方式健康者早期致死风险最低(OR 0.3,95%CI 0.1-0.7)
  • 联合家族史、PRS、罕见变异与生活方式可改善早期致死风险识别

核心结论

  • 联合家族史、DNA修复基因罕见变异、PRS和生活方式因素可能改善前列腺癌早期致死与致死风险识别。

研究设计与样本

  • 研究纳入两个前瞻性队列中966例前列腺癌患者,富集高危局限期疾病并具备胚系遗传数据。

主要发现

  • 共观察289例致死包括77例早期致死,末次随访中位年龄84.3岁。
  • 早期致死病例中家族史占23% vs 15%、高PRS占47% vs 36%、罕见变异占14% vs 7.8%。
  • ≥2个遗传因素与早期致死风险升高相关(OR 3.5,95%CI 1.8-7.0),并与75岁前诊断的高危局限期患者10年致死风险升高相关。
  • 无遗传因素且健康者早期致死风险最低(OR 0.3,95%CI 0.1-0.7),相比有任一遗传因素且不健康者。
  • 早期致死性疾病模式与早期致死性疾病相似。

临床怎么用

  • 对前列腺癌患者可整合家族史、PRS、DNA修复基因罕见变异与生活方式进行早期致死风险分层。

局限性

  • 研究数据有限,无法进行更详细分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: In men with prostate cancer, one-third of deaths occur before the age of 75 yr. There remains a need to characterize heritable and environmental risk factors for these early deaths. This study aims to improve risk stratification for early lethal outcomes among prostate cancer patients with genetic factors beyond family history and with modifiable factors. METHODS: This study included 966 prostate cancer patients, enriched for high-risk localized disease and with germline genetic data, in two prospective cohorts. Three genetic factors (family history of prostate cancer, polygenic risk score [PRS] in the top 20%, and rare variants in DNA repair genes) and a lifestyle score were examined for their association with early lethal (metastases/prostate cancer death before the age of 75 yr) compared with nonlethal cases using logistic regression and by calculating 10-yr lethal disease risks. KEY FINDINGS AND LIMITATIONS: In total, 289 lethal, including 77 early lethal, cases were observed (median age at the end follow-up: 84.3 yr). Early lethal cases had higher percentages of men with a family history (23% vs 15%), a high PRS (47% vs 36%), and rare variants (14% vs 7.8%). Having two or more genetic factors was strongly associated with increased odds of early lethal disease (odds ratio [OR], 3.5; 95% confidence interval [CI], 1.8-7.0) and linked to higher 10-yr lethal disease risks in high-risk localized patients diagnosed before the age of 75 yr. Healthy men with none of the genetic factors had the lowest odds of early lethal disease (OR, 0.3: 95% CI, 0.1-0.7), compared with unhealthy men with any genetic factor. The pattterns were similar for early fatal disease. The study had limited data for more detailed analyses. CONCLUSIONS AND CLINICAL IMPLICATIONS: The combination of family history with rare variants, a PRS, and lifestyle factors may improve the identification of prostate cancer patients at risk of early lethal and fatal disease.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Zhang Z, Zhang Y, Stopsack KH, et al. Identifying Patients at Risk of Early Lethal Prostate Cancer by Integrating Family History, Polygenic Risk Score, Rare Variants in DNA Repair Genes, and Lifestyle Factors. Eur Urol Oncol. 2025. PMID: 40187970. doi:10.1016/j.euo.2025.03.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。